Genvoya Description

elvitegravir + cobicistat + emtricitabine + tenofovir




DCH Auriga
Full Prescribing Info
Each Genvoya tablet contains 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine and tenofovir alafenamide fumarate equivalent to 10 mg of tenofovir alafenamide.
Elvitegravir, an antiretroviral medicine known as an integrase inhibitor.
Cobicistat, a booster (pharmacokinetic enhancer) of the effects of elvitegravir.
Emtricitabine, an antiretroviral medicine known as a nucleoside reverse transcriptase inhibitor (NRTI).
Tenofovir alafenamide, an antiretroviral medicine known as a nucleotide reverse transcriptase inhibitor (NtRTI).
Excipients/Inactive Ingredients: Lactose (as monohydrate), microcrystalline cellulose, croscarmellose sodium, hydroxypropyl cellulose, silicon dioxide, sodium lauryl sulphate, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol/macrogol, talc, FD&C Blue #2/Indigo carmine aluminium lake and iron oxide yellow.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in